Read More Pharma Industry News Citius Oncology (Nasdaq: CTOR) bets on Verix AI to supercharge LYMPHIR’s commercial rollout in CTCL Find out how Citius Oncology is leveraging Verix AI to power the commercial launch of LYMPHIR and accelerate uptake in CTCL. bySrinathNovember 23, 2025